Johnson & Johnson to stop selling talc-based baby powder globally stuff.co.nz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from stuff.co.nz Daily Mail and Mail on Sunday newspapers.
Johnson & Johnson to pay USD 417 million to woman in talcum powder cancer claim case
Johnson & Johnson to pay USD 417 million to woman in talcum powder cancer claim case
The Verdict In Favour Of California Resident Eva Echeverria Was The Largest Yet In Lawsuits Alleging J&J Failed To Warn Consumers About The Cancer Risks Of Its Talc-based Products.
News Nation Bureau | Edited By : Neha Singh | Updated on: 22 Aug 2017, 09:49:05 AM
New Delhi:
Los Angeles jury have asked Johnson & Johnson to pay $417-million to a woman who have claimed that she developed ovarian cancer after using the company’s talc-based products.
The verdict in favour of California resident Eva Echeverria was the largest yet in lawsuits alleging J&J failed to warn consumers about the cancer risks of its talc-based products.
Analysts at Citigroup on Monday added shares of TESARO Inc (NASDAQ: TSRO) to its Citigroup s Focus List while at the same time removing shares of Medivation Inc (NASDAQ: MDVN) from the same list. Tesaro: Leadership Position The analysts, led by Yaron Werber, MD, noted that. Read More. Don t Miss Any Updates! News Directly in Your Inbox Subscribe to:
A jury in California ordered Johnson & Johnson (NYSE: JNJ) to pay $417 million to a woman who claimed the company’s talcum powder gave her cancer, the latest in a recent string of successful lawsuits.
Eva Echeverria, 63, said she started using baby powder when she was 11 years old. She. Read More. Don t Miss Any Updates! News Directly in Your Inbox Subscribe to: